The upcoming clinical trial evaluating the BalanceBelt, a vibrotactile device designed to improve gait in patients with impaired balance, reflects ongoing advancements in medical device research. Hosted by Johns Hopkins University and currently marked as ‘Not yet recruiting’ on ClinicalTrials.gov, this study aims to address conditions such as vestibular hypofunction, ataxia, and general gait impairment.
Published on November 29, 2025, this trial emphasizes new technologies to support patients with balance disorders.
In this article
- What is BalanceBelt?
- What are the trial objectives?
- Who is eligible?
- FAQ
- Conclusion
- Disclaimer
- Announcement and Link
What is BalanceBelt?
The BalanceBelt is a wearable device that delivers vibrotactile feedback to assist individuals experiencing balance-related gait issues. By transmitting subtle vibrations to guide movement, it intends to support patients in recognizing spatial orientation and addressing issues caused by vestibular dysfunction or other balance impairments.
What are the trial objectives?
This study focuses on measuring the effectiveness of vibrotactile technology for improving patient gait in clinical settings. Researchers are investigating whether regular use of BalanceBelt can restore confidence and stability in walking for patients diagnosed with vestibular hypofunction, ataxia, or other gait-related conditions. Safety assessments and user experience insights will also be part of the evaluation.
Significance for Medical Device Regulation
As the device undergoes clinical investigation, findings from this trial may inform future submissions to regulatory bodies, highlighting key performance and safety data relevant under MDR Annex XIV provisions.
Who is eligible?
The trial will recruit participants with documented vestibular hypofunction, ataxia, or other diagnostic gait impairments. As recruitment has not yet begun, further details about inclusion and exclusion criteria are anticipated to be provided directly through ClinicalTrials.gov pages or other linked updates.
FAQ
- What is vibrotactile feedback?
Vibrotactile feedback uses gentle vibrations on the skin to provide sensory cues that assist in movement or spatial recognition. - Is BalanceBelt cleared by regulators?
This trial is part of ongoing evaluations. Clearance status for the device itself will depend on outcomes and reported performance per standard regulatory pathways. - How long will the study last?
While specific timelines are unannounced, detailed durations and milestones will likely depend on recruitment phases and observed patient outcomes.
Conclusion
The BalanceBelt study reflects growing interest in wearable medical technologies for addressing gait impairment and balance disorders. Patients and clinicians alike may benefit from upcoming insights into its efficacy.
Disclaimer
The information provided in this article is for professional reference and educational purposes. It is not a substitute for legal or clinical advice concerning medical devices or treatments.
Announcement and Link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07253532?term=medical+device